Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Klupp

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 11, 2013
Sotrastaurin in calcineurin inhibitor-free regimen using everolimus in de novo kidney transplant recipientsH Tedesco-Silva, M M L Kho, A Hartmann, et al.
Transplantation Proceedings|March 20, 1999
Quadruple induction therapy including antithymocyte globulin or interleukin-2 receptor antibody or FK 506-based induction therapy after liver transplantationR Lohmann, J M Langrehr, J Klupp, et al.
Clinical Transplantation|August 1, 1998
A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantationJ M Langrehr, M Glanemann, O Guckelberger, et al.
Deutsche Medizinische Wochenschrift (1946)|February 18, 2005
[Clinical results of intestinal and multivisceral transplantation at the Charité, Berlin. A case series]A Pascher, J Klupp, R J Schulz, et al.
Transplantation Proceedings|October 8, 2003
Immunosuppressive management following intestinal transplantation in adult patientsA R Mueller, A Pascher, K P Platz, et al.
Transplantation Proceedings|June 24, 1998
A randomized trial comparing anti-interleukin-2 receptor antibody and placebo for immunosuppressive therapy after OLTJ M Langrehr, M Glanemann, A Schneller, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 15, 2013
Efficacy of sotrastaurin plus tacrolimus after de novo kidney transplantation: randomized, phase II trial resultsG R Russ, H Tedesco-Silva, D R Kuypers, et al.
Zeitschrift Fur Gastroenterologie|November 24, 2004
[Consensus-recommendations for sirolimus in liver transplantation]M Golling, T Becker, C Broelsch, et al.
Transplantation|June 27, 1997
A prospective randomized trial comparing interleukin-2 receptor antibody versus antithymocyte globulin as part of a quadruple immunosuppressive induction therapy following orthotopic liver transplantationJ M Langrehr, N C Nüssler, U Neumann, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 11, 2013
Sotrastaurin in calcineurin inhibitor-free regimen using everolimus in de novo kidney transplant recipientsH Tedesco-Silva, M M L Kho, A Hartmann, et al.
Transplantation Proceedings|March 20, 1999
Quadruple induction therapy including antithymocyte globulin or interleukin-2 receptor antibody or FK 506-based induction therapy after liver transplantationR Lohmann, J M Langrehr, J Klupp, et al.
Clinical Transplantation|August 1, 1998
A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantationJ M Langrehr, M Glanemann, O Guckelberger, et al.
Deutsche Medizinische Wochenschrift (1946)|February 18, 2005
[Clinical results of intestinal and multivisceral transplantation at the Charité, Berlin. A case series]A Pascher, J Klupp, R J Schulz, et al.
Transplantation Proceedings|October 8, 2003
Immunosuppressive management following intestinal transplantation in adult patientsA R Mueller, A Pascher, K P Platz, et al.
Transplantation Proceedings|June 24, 1998
A randomized trial comparing anti-interleukin-2 receptor antibody and placebo for immunosuppressive therapy after OLTJ M Langrehr, M Glanemann, A Schneller, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 15, 2013
Efficacy of sotrastaurin plus tacrolimus after de novo kidney transplantation: randomized, phase II trial resultsG R Russ, H Tedesco-Silva, D R Kuypers, et al.
Zeitschrift Fur Gastroenterologie|November 24, 2004
[Consensus-recommendations for sirolimus in liver transplantation]M Golling, T Becker, C Broelsch, et al.
Transplantation|June 27, 1997
A prospective randomized trial comparing interleukin-2 receptor antibody versus antithymocyte globulin as part of a quadruple immunosuppressive induction therapy following orthotopic liver transplantationJ M Langrehr, N C Nüssler, U Neumann, et al.
Pageof 6